Prolonged treatment of Menetrier's disease with an oral anticholinergic drug

R. L. Smith, D. W. Powell

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

There is considerable evidence, both in patients with Menetrier's disease and from animal models of protein-losing gastropathy, that antisecretory drugs can acutely decrease or abolish gastric plasma protein shedding. Serial measurements of serum protein components were performed in a patient with Menetrier's disease before, during, and after long term treatment with propantheline bromide. Total serum protein concentration increased significantly during the treatment period from 4.3 ± 0.50 to 5.9 ± 0.55 g per dl during treatment, while albumin increased from a pretreatment value of 2.5 ± 0.12 to 3.4 ± 0.16 g per dl. The improvement in serum proteins and symptoms continued after therapy was stopped. Intensive anticholinergic drug therapy should be tried in this disease before resorting to gastrectomy.

Original languageEnglish (US)
Pages (from-to)903-906
Number of pages4
JournalGastroenterology
Volume74
Issue number5 PART 1
StatePublished - 1978
Externally publishedYes

Fingerprint

Hypertrophic Gastritis
Cholinergic Antagonists
Blood Proteins
Pharmaceutical Preparations
Propantheline
Therapeutics
Gastrectomy
Albumins
Stomach
Animal Models
Drug Therapy
Proteins

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Smith, R. L., & Powell, D. W. (1978). Prolonged treatment of Menetrier's disease with an oral anticholinergic drug. Gastroenterology, 74(5 PART 1), 903-906.

Prolonged treatment of Menetrier's disease with an oral anticholinergic drug. / Smith, R. L.; Powell, D. W.

In: Gastroenterology, Vol. 74, No. 5 PART 1, 1978, p. 903-906.

Research output: Contribution to journalArticle

Smith, RL & Powell, DW 1978, 'Prolonged treatment of Menetrier's disease with an oral anticholinergic drug', Gastroenterology, vol. 74, no. 5 PART 1, pp. 903-906.
Smith, R. L. ; Powell, D. W. / Prolonged treatment of Menetrier's disease with an oral anticholinergic drug. In: Gastroenterology. 1978 ; Vol. 74, No. 5 PART 1. pp. 903-906.
@article{56108c669eea4d0fa6a8ad63fb2f75a8,
title = "Prolonged treatment of Menetrier's disease with an oral anticholinergic drug",
abstract = "There is considerable evidence, both in patients with Menetrier's disease and from animal models of protein-losing gastropathy, that antisecretory drugs can acutely decrease or abolish gastric plasma protein shedding. Serial measurements of serum protein components were performed in a patient with Menetrier's disease before, during, and after long term treatment with propantheline bromide. Total serum protein concentration increased significantly during the treatment period from 4.3 ± 0.50 to 5.9 ± 0.55 g per dl during treatment, while albumin increased from a pretreatment value of 2.5 ± 0.12 to 3.4 ± 0.16 g per dl. The improvement in serum proteins and symptoms continued after therapy was stopped. Intensive anticholinergic drug therapy should be tried in this disease before resorting to gastrectomy.",
author = "Smith, {R. L.} and Powell, {D. W.}",
year = "1978",
language = "English (US)",
volume = "74",
pages = "903--906",
journal = "Gastroenterology",
issn = "0016-5085",
publisher = "W.B. Saunders Ltd",
number = "5 PART 1",

}

TY - JOUR

T1 - Prolonged treatment of Menetrier's disease with an oral anticholinergic drug

AU - Smith, R. L.

AU - Powell, D. W.

PY - 1978

Y1 - 1978

N2 - There is considerable evidence, both in patients with Menetrier's disease and from animal models of protein-losing gastropathy, that antisecretory drugs can acutely decrease or abolish gastric plasma protein shedding. Serial measurements of serum protein components were performed in a patient with Menetrier's disease before, during, and after long term treatment with propantheline bromide. Total serum protein concentration increased significantly during the treatment period from 4.3 ± 0.50 to 5.9 ± 0.55 g per dl during treatment, while albumin increased from a pretreatment value of 2.5 ± 0.12 to 3.4 ± 0.16 g per dl. The improvement in serum proteins and symptoms continued after therapy was stopped. Intensive anticholinergic drug therapy should be tried in this disease before resorting to gastrectomy.

AB - There is considerable evidence, both in patients with Menetrier's disease and from animal models of protein-losing gastropathy, that antisecretory drugs can acutely decrease or abolish gastric plasma protein shedding. Serial measurements of serum protein components were performed in a patient with Menetrier's disease before, during, and after long term treatment with propantheline bromide. Total serum protein concentration increased significantly during the treatment period from 4.3 ± 0.50 to 5.9 ± 0.55 g per dl during treatment, while albumin increased from a pretreatment value of 2.5 ± 0.12 to 3.4 ± 0.16 g per dl. The improvement in serum proteins and symptoms continued after therapy was stopped. Intensive anticholinergic drug therapy should be tried in this disease before resorting to gastrectomy.

UR - http://www.scopus.com/inward/record.url?scp=0018189846&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018189846&partnerID=8YFLogxK

M3 - Article

C2 - 640345

AN - SCOPUS:0018189846

VL - 74

SP - 903

EP - 906

JO - Gastroenterology

JF - Gastroenterology

SN - 0016-5085

IS - 5 PART 1

ER -